Brandon M. White was mentioned as counsel for Mylan Inc. in "Fed. Circ. Axes Teva MS Drug Patent In High Court Remand," a Law360 article, regarding the ruling on the patent on Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone, naming it "invalid".